Rakovina highlighted the development of its kt-3000 drug candidates as a potential treatment of Ewing sarcoma and other soft tissue tutors..

FDA has granted the request for a meeting to review the clinical trial protocol for its Phase 3 study in high-risk COVID-19 outpatients.

The CPP brings together businesses, policy makers, and NGOs to work together and create a national solution to plastic waste and pollution..

Rakovina Therapeutics - committed to advancing new cancer therapies presented at the American Association of Cancer Research Annual Meeting.

The data presented suggested promising activity for bi-functional kt-4000 series compounds...

Rakovina’s presentation will highlight the development of its drug candidates as a potential treatment of sarcomas and soft tissue tumors..

he article outlines the positive impact of apabetalone in the investigator-led pulmonary arterial hypertension (PAH) pilot study, APPRoAcH-p

Rakovina Therapeutics presentation will highlight pre-clinical research related to its novel kt-4000 series.

Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response (DDR) technologies.

Resverlogix has initiated the first Brazilian and a second Canadian site for its Phase 2b clinical trial for COVID-19 treatment..

Resverlogix’s clinical program is focused on evaluating apabetalone for the treatment of cardiovascular disease and COVID-19...

The body’s cells have their DNA damaged daily. They correct this damage through a series of processes...

Resverlogix researchers seek to find corrupted messages sent by DNA and correct the message that reaches our genes.

A further five sites in Brazil and a third Canadian site, in Toronto, Ontario, will also be coming on line soon.

Enrollment and dosing of patients has commenced in a Phase 2b study at a site at the University of Alberta Hospital in Edmonton.

"Resverlogix has partnered with EVERSANA ™, a pioneer of next generation commercial services to the global life sciences industry, to...

Resverlogix Corp. (TSX: RVX) is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic...

"Rakovina (RKV) is partnering with St. Baldrick's Foundation to develop treatments for childhood bone cancer. It was selected to join a...

Funding will support the development of new research infrastructure for screening and optimization of potential drug candidates...

RVX will be hosting a corporate update webcast and conference call on Thursday, December 16th, 2021 at 2:00 pm MST.

Rakovina has been selected to join a three year US$975,000 (CDN1,297,000) research program funded by the St. Baldrick’s Foundation..

This initiative will provide the necessary investments to advance apabetalone for potential treatment of Covid in the Arab-African Economy

Apabetalone is the only drug of its class with a well-established safety record in human clinical trials...

Rakovina has been invited to present at the 6th biennial Canadian Cancer Research Conference which is being held virtually Nov. 8-11, 2021.

Presentation highlights pre-clinical data from Rakovina Therapeutics’ novel kt-3000 series dual PARP-HDAC inhibitors..

Apabetalone is the only drug of its class with a well-established safety record in human clinical trials, with well over 4200 patient-years

The granted patent claims cover the composition of matter and uses of drug candidates from Rakovina Therapeutics’ kt-2000 series...

"In February 2020, Apabetalone became the first therapy of its kind to have been granted US FDA Breakthrough Therapy Designation, for a...

Successful Completion and Promising Results of Investigator-led APPROACH-p Trial Sets the Stage for a Larger Multicenter Trial

Velada brand cannabis products both online and in store in the province of ON starting January 2022

The conference has attracted academics, scientists, and pharmaceutical industry representatives from across the globe.....

TGSC has also initiated a podcast marketing campaign with AdvertiseCast to continue expanding their e-commerce presence throughout NA..

Resverlogix and EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19...

Good Shroom, through its wholly owned subsidiary, Teonan, manufactures and sells functional beverages under its two brands, Teonan, a...

MUSH is expected to gain exposure to Ecotrend Ecologics Ltd.'s network of 2,500 retailers in Canada, which includes Whole Foods, Well.ca...

Rakovina is pleased to report steady progress in research activities as they establish Rakovina as a publicly listed company...

Agreement allows for Hepalink to purchase 10% secured convertible debentures in the aggregate principal amount of US$6 million...

The introductory order of 3,000 units allows to establish a relationship with Good Food and expect, will lead to additional orders...

Rakovina announced the formation of its Scientific Advisory Board. Made up of experts in biology, medicinal chemistry and pharmacology...

“Amazon’s Choice” designation is achieved by high star rating, competitive price, low return rate, consistent inventory, and high sales..

The company’s focus is the development of new cancer treatments and is researching and developing new precision medicines targeting critical

Micron Technologies has submitted its N95 Model 8800 face masks to NIOSH and is confident it will obtain NIOSH certification...

Dr. Cherrington is an accomplished life science executive with a record of success bringing drug candidates through to commercialization...

The company will focus on the development of novel DNA-damage repair (DDR) inhibitors for the treatment of cancer

Micron Technologies' three-ply medical grade face masks and N95 medical grade face masks have been approved for sale by Walmart..

This collaborative research effort, employing state-of-the-art methods, has demonstrated apabetalone’s potential...

Following new published evidence of apabetalone's benefit in COVID-19 Resverlogix is announcing the initiation of human clinical trials..

Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model..

Liquid Avatar provides users, at no cost, digital tools to create, manage and control their biometric based, Self Sovereign Identity....

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26 under the ticker PSYK on the NEO Exchange